Robert D. Hardie, 10% Owner at Acumen Pharmaceuticals, Inc. (ABOS), bought 750,000 shares at $16.00 ($12.0M) on 2021-07-06, disclosed to the SEC on 2021-07-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.